PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2023-04-04 (3)

Date Title Company
04-Apr-2023 FDA Grants Accelerated Approval for PADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA® (pembrolizumab) for First-Line Treatment of Locally Advanced or Metastatic Urothelial Cancer Businesswire